Valuation: Highnoon Laboratories Limited

Market Cap 52.11B 188M 163M 152M 139M 263M 17.92B 267M 1.79B 703M 8.92B 705M 689M 29.91B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 52.11B 188M 163M 152M 139M 263M 17.92B 267M 1.79B 703M 8.92B 705M 689M 29.91B EV / Sales 2026 *
1.71x
EV / Sales 2027 * 1.53x
Free-Float
50.02%
Yield 2026 *
4.58%
Yield 2027 * 5.29%
1 day+1.13%
1 week+2.31%
1 month-2.39%
3 months+7.67%
6 months-2.67%
Current year-3.82%
1 week 955
Extreme 955
1,057
1 month 921
Extreme 921
1,075
Current year 755.56
Extreme 755.56
1,101
1 year 755.56
Extreme 755.56
1,241
3 years 330
Extreme 330
1,241
5 years 322.1
Extreme 322.1
1,241
10 years 127.86
Extreme 127.8558
1,241
Manager TitleAgeSince
Chief Executive Officer - 01/04/2015
Chief Executive Officer 63 01/01/1996
Director of Finance/CFO - 01/04/2020
Director TitleAgeSince
Chairman - 07/09/2012
Chairman - -
Director/Board Member 36 -
Change 5-day change 1-year change 3-year change Capi.($)
+1.13%+2.31%-10.59%+159.52% 188M
-0.53%-3.95%+50.70%+153.56% 1,024B
+0.21%-2.68%+53.20%+51.79% 618B
-2.51%-3.25%+28.54%+68.94% 443B
+0.06%-0.42%+37.53%+30.67% 349B
-0.69%-0.30%+13.76%+12.83% 264B
-7.37%-4.40%-0.74%-44.28% 209B
-0.64%+2.43%+29.74%+65.93% 208B
-0.82%+0.70%+15.05%+72.05% 162B
+0.40%+1.92%+6.47%-29.77% 143B
Average -1.08%-1.26%+22.37%+54.12% 341.91B
Weighted average by Cap. -1.00%-2.02%+36.14%+71.91%

Financials

2026 *2027 *
Net sales 30.4B 109M 95.18M 88.59M 81.34M 154M 10.45B 156M 1.04B 410M 5.2B 411M 402M 17.45B 34.16B 123M 107M 99.57M 91.41M 173M 11.75B 175M 1.17B 461M 5.85B 462M 452M 19.61B
Net income - -
Net Debt - -
Logo Highnoon Laboratories Limited
Highnoon Laboratories Limited is a Pakistan-based company that is engaged in the manufacturing, importing, selling, and marketing of pharmaceutical and related consumer products. Its product categories include cardiology, metabolic, gastroenterology, musculoskeletal, anti-infective, obstetrics and gynecology, pediatrics, allergy, respiratory, and urology. Its cardiology products include Cuziper, Hitica, Apiban, Misar, and Herbesser. Its metabolic products include Daploz, Tagip, Diajard, and Nylomet. Its gastroenterology products include Rabecid, Racedo, Skilax, and Fosbu. Its musculoskeletal products include Kydor, Hilin, Airtal, and Tamadol. Its anti-infective products include Evacef, Maxum, Efix, and Cefia. Its obstetrics and gynecology products include Hitase. Its pediatrics product includes Tres Orix Forte. Its allergy products include Leviva and Kestine. Its respiratory products include Combivair Forte, Glynvair, Betatec, Ultivair, and Montit. Its urology products include Prostam.
Employees
2,563
Date Price Change Volume
31/07/26 PKR 983.46 +1.13% 3,109
30/07/26 PKR 972.46 -1.58% 19,249
29/07/26 PKR 988.11 -0.80% 8,339
28/07/26 PKR 996.04 -0.39% 6,606
27/07/26 PKR 999.95 +4.03% 34,747
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
983.46PKR
Average target price
1,121.00PKR
Spread / Average Target
+13.99%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. HINOON Stock